Treatment of Dyshidrotic Eczema
The first-line treatment for dyshidrotic eczema is topical corticosteroids, with medium to high-potency formulations applied twice daily for up to 4 weeks, followed by maintenance therapy using intermittent application (1-2× weekly) to prevent flares. 1
Stepwise Treatment Approach
First-Line Therapy
- Topical corticosteroids:
- For hands/feet (non-sensitive areas): Medium to high-potency steroids (Class 2-3)
- Apply twice daily for initial treatment (up to 4 weeks)
- Reassess after 2 weeks to evaluate response 1
- High-potency steroids (Class 1-2) reserved for thick, lichenified, or treatment-resistant lesions
Maintenance Therapy
- Reduce frequency to 1-2 times weekly after improvement to prevent flares
- Apply emollients 3-8 times daily, even when skin appears normal
- Ointments provide maximum occlusion (best for very dry skin)
- Creams offer good balance of hydration and acceptability
- Apply moisturizers immediately after bathing to lock in moisture 1
For Refractory Cases
- Topical calcineurin inhibitors: Tacrolimus 0.1% ointment can be used as rotational therapy with corticosteroids for chronic cases 2
- Consider referral to specialist care for:
- Diagnostic uncertainty
- Failure to respond to appropriate topical steroids
- Need for second-line treatment 1
Addressing Underlying Factors
Infection Management
- Treat clinically evident infections with appropriate antibiotics
- Consider antiseptic washes with aqueous chlorhexidine 0.05% for erosive lesions
- Bleach baths with 0.005% sodium hypochlorite twice weekly can help prevent infections 1
Trigger Identification and Avoidance
- Metal allergy consideration:
Associated Conditions
- Hyperhidrosis management:
- If excessive sweating is present, treating hyperhidrosis may improve dyshidrotic eczema
- Medications like oxybutynin have shown impressive results in patients with both conditions 5
Lifestyle Modifications
- Use gentle, pH-neutral synthetic detergents instead of soap
- Avoid irritants such as perfumes, deodorants, and alcohol-based lotions
- Avoid irritant clothing and extremes of temperature
- Keep nails short to prevent secondary infections from scratching 1
Advanced Therapies for Severe Cases
- Phototherapy (narrowband UVB) for moderate to severe cases not responding to topical treatments
- Systemic agents for severe, refractory cases (under specialist supervision):
- Dupilumab, tralokinumab (biologics)
- Abrocitinib, baricitinib, upadacitinib (JAK inhibitors)
- Cyclosporine, methotrexate, azathioprine, mycophenolate 1
Caution: Systemic corticosteroids are not recommended due to the risk of rebound flares and adverse events 1
Important Monitoring Considerations
- Watch for adverse effects of topical corticosteroids, including skin atrophy, striae, telangiectasia, and purpura
- Prolonged use of medium to high-potency steroids beyond 4 weeks increases the risk of skin atrophy 1
- Regular follow-up is essential to assess treatment response and adjust therapy accordingly